A Better Way to Measure Cognitive Safety & Tolerability

July 30, 2020


Learn how to leverage integrated digital cognitive assessments and patient reports to achieve advanced insights, streamlined delivery and lower burden.

Watch the webinar to learn:

  • The value of assessing cognitive safety and tolerability throughout the drug development process
  • Addressing current regulatory guidance
  • How data from objective performance-based assessments can be integrated with other sources of information to inform trial decision-making
  • Key considerations for selecting and optimizing computerized cognitive assessments
  • Lessons learned from global cognitive safety studies across oncology, cardiovascular, migraine, epilepsy

Featured Speakers

  • Chris Edgar, Senior Vice President, Clinical Science, Cogstate
  • Ken Faulkner, Vice President, eCOA Scientific Services, ERT

Access Recording

Back to Webinars